Susceptibility to urinary bladder cancer: Relevance of rs9642880[T], GSTM1 0/0 and occupational exposure

Pharmacogenetics and Genomics

Volumn 19, Issue 11, 2009, Pages 903-906

  Golka, Klaus ^a   Hermes, Matthias ^a   Selinski, Silvia ^a,b   Blaszkewicz, Meinolf ^a   Bolt, Hermann M ^a   Roth, Gerhard ^c   Dietrich, Holger ^c   Prager, Hans Martin ^d   Ickstadt, Katja ^b   Hengstler, Jan G ^a  

^a LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

^c Paul Gerhardt Foundation   (Germany)

^d Institute for Occupational   (Germany)

Author keywords

Aromatic amines; C myc; GSTM1; Polycyclic aromatic hydrocarbons; Single nucleotide polymorphisms; Urinary bladder cancer

Indexed keywords

AROMATIC AMINE; AZO DYE; CARCINOGEN; GLUTATHIONE TRANSFERASE M1; POLYCYCLIC AROMATIC HYDROCARBON;

AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE;

GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE; URINARY BLADDER NEOPLASMS;

EID: 74049083239     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e328331b554     Document Type: Article

References (10)

1. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008; 40:1307-1312.
2. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10:1239-1248. (Pubitemid 34027754)
3. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamlne N-acetyltransferase 2, glutathione S-transferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P 450 enzymes as modulators of bladder cancer risk. Cancer Res 1996; 56:3915-3925. (Pubitemid 26284739)
4. Kempkes M, Golka K, Reich S, Reckwitz T, Bolt HM. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol 1996; 71:123-126.
5. Engel LS, Taioli E, Pfeiffer R, Garcla-Closas M, Marcus PM, Lan Q, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002; 156:95-109. (Pubitemid 34759966)
6. Hengstler JG, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 1998; 154:47-85.
7. Golka K, Reckwitz T, Kempkes M, Cascorbi I, Blaszkewicz M, Reich SE, et al. N-Acetyltransferase 2 (NAT2) and glutathione S-transferase μ (GSTM 1) in bladder-cancer patients in a highly industrialized area. Int J Occup Environ Health 1997;3:105-110. (Pubitemid 127816931)
8. Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, et al. GST, NAT, SULT1A1, CYP1 B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004; 110:598-604. (Pubitemid 38658026)
9. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66:1191-1308. (Pubitemid 11063920)
10. Covolo L, Placidi D, Gelatti U, Carta A, Scotto Di Carlo A, Lodetti P, et al. Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study. Eur J Epidemiol 2008; 23:355-362.